Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NLGN1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | NLGN1 |
| Key Genes/Proteins | ACSL4, Actin, ADNP, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID |
| Related Diseases | Aging, Als, ALS, Alzheimer, Alzheimer's disease |
| Related Pathways | Amyloid |
Knowledge base pages for this entity
graph TD
NLGN1["NLGN1"]
style NLGN1 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
NLGN1 -->|"binds"| heparan_sulfate["heparan sulfate"]
NLGN1 -->|"interacts"| PSD95([PSD95])
NLGN1 -->|"participates in"| synapse["synapse"]
NLGN1 -->|"interacts"| neurexin([neurexin])
NLGN1 -->|"regulates"| GluA1([GluA1])
NLGN1 -->|"regulates"| Trans_Synaptic_Adhesion_Molecu["Trans-Synaptic Adhesion Molecule Modulation"]
NLGN1 -.->|"inhibits"| Alzheimer["Alzheimer"]
NLGN1 -.->|"inhibits"| Dementia["Dementia"]
NLGN1 -.->|"inhibits"| Als["Als"]
h_fdaae8d9["h-fdaae8d9"] -->|"targets"| NLGN1
Hevin([Hevin]) -->|"regulates"| NLGN1
FN([FN]) -->|"regulates"| NLGN1
NRXN2A([NRXN2A]) -->|"interacts"| NLGN1
amyloid_beta_oligomers([amyloid-beta oligomers]) -->|"modulates"| NLGN1
NRXN3([NRXN3]) -->|"interacts"| NLGN1
EXOSOMES([EXOSOMES]) -.->|"inhibits"| NLGN1
ALZHEIMER([ALZHEIMER]) -.->|"inhibits"| NLGN1
NRXN2([NRXN2]) -->|"interacts"| NLGN1
DEMENTIA([DEMENTIA]) -.->|"inhibits"| NLGN1| Target | Relation | Type | Str |
|---|---|---|---|
| heparan sulfate | binds | chemical | 0.90 |
| neurons | expressed_in | cell_type | 0.80 |
| PSD95 | interacts_with | protein | 0.80 |
| neurexin | interacts_with | protein | 0.80 |
| GluA1 | regulates | protein | 0.80 |
| neurons | activates | cell_type | 0.70 |
| hippocampus | expressed_in | brain_region | 0.70 |
| Trans-Synaptic Adhesion Molecule Modulation | regulates | mechanism | 0.70 |
| Multiple Sclerosis | expressed_in | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Neurodegeneration | expressed_in | disease | 0.65 |
| Neurodegeneration | causes | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Aging | expressed_in | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Autism | encodes | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Autism | regulates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Autism | activates | disease | 0.65 |
| Dementia | inhibits | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Aβ | inhibits | protein | 0.60 |
| Amyloid-Beta | inhibits | protein | 0.60 |
| MTORC1 | encodes | gene | 0.60 |
| Mtor | encodes | pathway | 0.60 |
| SYNAPSE | associated_with | gene | 0.60 |
| Aβ | therapeutic_target | protein | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| SYNAPSE | regulates | gene | 0.60 |
| cortex | expressed_in | brain_region | 0.60 |
| Alzheimer's disease | biomarker_for | disease | 0.60 |
| synaptic plasticity | participates_in | pathway | 0.60 |
| unfolded protein response | participates_in | pathway | 0.60 |
| neurons | protects_against | cell_type | 0.60 |
| neurons | associated_with | cell_type | 0.60 |
| neurons | interacts_with | cell_type | 0.60 |
| Alzheimer's disease | associated_with | disease | 0.60 |
| autism spectrum disorder | associated_with | disease | 0.60 |
| synaptic plasticity | involved_in | pathway | 0.60 |
| Neuron | activates | cell_type | 0.60 |
| Neuron | interacts_with | cell_type | 0.60 |
| SYNAPSE | activates | gene | 0.60 |
| Synaptic Plasticity | activates | pathway | 0.60 |
| AMYLOID-BETA | inhibits | gene | 0.60 |
| Neuron | inhibits | cell_type | 0.60 |
| MTORC1 | activates | gene | 0.60 |
| Mtor | activates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-fdaae8d9 | targets | hypothesis | 0.90 |
| Hevin | regulates | protein | 0.80 |
| FN | regulates | gene | 0.70 |
| AMYLOID-BETA | inhibits | gene | 0.60 |
| NRXN3 | regulates | gene | 0.60 |
| NRXN2 | regulates | gene | 0.60 |
| PSP | inhibits | gene | 0.60 |
| NGN1 | regulates | gene | 0.60 |
| NGN2 | regulates | gene | 0.60 |
| MEF2C | regulates | gene | 0.60 |
| EPHA5 | regulates | gene | 0.60 |
| ADNP | expressed_in | gene | 0.60 |
| NRXN2A | interacts_with | protein | 0.60 |
| amyloid-beta oligomers | modulates | protein | 0.60 |
| NRXN3 | interacts_with | protein | 0.60 |
| NRXN2 | interacts_with | gene | 0.60 |
| NPTX2 | interacts_with | gene | 0.60 |
| NRXN1 | activates | gene | 0.60 |
| RORB | activates | gene | 0.60 |
| KCNIP4 | activates | gene | 0.60 |
| APP | activates | gene | 0.60 |
| NCAM2 | activates | gene | 0.60 |
| RORA | activates | gene | 0.60 |
| FGF14 | activates | gene | 0.60 |
| GRIN2A | activates | gene | 0.60 |
| NRXN1 | regulates | gene | 0.60 |
| DCC | associated_with | gene | 0.60 |
| NLGN2 | inhibits | gene | 0.60 |
| GEPHYRIN | interacts_with | gene | 0.60 |
| NRXN1 | interacts_with | gene | 0.60 |
| NLGN3 | associated_with | gene | 0.60 |
| TSC1 | activates | gene | 0.60 |
| TSC2 | activates | gene | 0.60 |
| EXOSOMES | inhibits | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| DEMENTIA | inhibits | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| AND | interacts_with | gene | 0.60 |
| NEURON | interacts_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.60 |
| SYNAPSE | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| NEURODEGENERATION | causes | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| AMYLOID | inhibits | gene | 0.60 |
| MTORC1 | activates | gene | 0.60 |
| MIRNAS | expressed_in | gene | 0.60 |
| NEURODEGENERATION | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Trans-Synaptic Adhesion Molecule Modulation | 0.544 | Alzheimer's Disease | Tau propagation mechanisms and therapeut |
| Trans-Synaptic Adhesion Molecule Modulation | 0.503 | neurodegeneration | Tau propagation mechanisms and therapeut |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 15 hypotheses Top: 0.814
neurodegeneration | 2026-04-03 | 42 hypotheses Top: 0.910
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Spp1 knockout prevents synaptic loss in AD mouse models | validation | Alzheimer's disease | 0.900 | 0.00 | Spp1 knockout AD mouse models | proposed | N/A |
| Adoptive transfer of TCRAβ-Tregs in AD mouse model | validation | Alzheimer's disease | 0.900 | 0.00 | transgenic mice expressing chi | proposed | N/A |
| AhR transcriptional regulation of NEP gene | exploratory | Alzheimer's disease | 0.850 | 0.00 | Cell culture system | proposed | N/A |
| Bioinformatics analysis and hub gene identification | exploratory | Alzheimer's disease | 0.800 | 0.00 | computational analysis of tran | proposed | N/A |
| Synaptic Vesicle Trafficking Dysfunction Validation in Parkinson's Dis | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,500,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| NRXN3-NLGN1 complex influences the development of depression induced by maternal [PMID:40286836] | Rong Y, Yan W, Gao Z, Yang Y, Xu C, Zhan | Brain research | 2025 | 0 |
| Membrane trafficking of synaptic adhesion molecules. [PMID:39322997] | ["Bogaciu C", "Rizzoli S"] | The Journal of physiology | 2025 | 0 |
| Activation of hypothalamic-pontine-spinal pathway promotes locomotor initiation [PMID:41353490] | ["Ji C", "Zhang Y", "Lin Z", "Zhao Z", " | Nature communications | 2025 | 0 |
| Molecular Signatures of Resilience to Alzheimer's Disease in Neocortical Layer 4 [PMID:39574639] | Dharshini SAP, Sanz-Ros J, Pan J, Tang W | bioRxiv : the preprint server | 2024 | 0 |
| Cross-disorder and disease-specific pathways in dementia revealed by single-cell [PMID:39265576] | Rexach JE, Cheng Y, Chen L, Polioudakis | Cell | 2024 | 0 |
| Organizing the synaptic junctions. [PMID:37060998] | ["Zhou Q"] | The Journal of biological chem | 2023 | 0 |
| A Neuroligin-1 mutation associated with Alzheimer's disease produces memory and [PMID:37260747] | Arias-Aragón F, Tristán-Clavijo E, Martí | iScience | 2023 | 0 |
| Reelin through the years: From brain development to inflammation. [PMID:37339050] | Alexander A, Herz J, Calvier L | Cell reports | 2023 | 0 |
| Molecular mechanisms of synaptogenesis. [PMID:36176941] | ["Qi C", "Luo L", "Feng I", "Ma S"] | Frontiers in synaptic neurosci | 2022 | 0 |
| In vivo nanoscopic landscape of neurexin ligands underlying anterograde synapse [PMID:36007521] | Nozawa K, Sogabe T, Hayashi A, Motohashi | Neuron | 2022 | 0 |
| Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for [PMID:33522967] | Camporesi E, Lashley T, Gobom J, Lantero | Acta neuropathologica communic | 2021 | 0 |
| PSD-95 binding dynamically regulates NLGN1 trafficking and function. [PMID:31138690] | Jeong J, Pandey S, Li Y, Badger JD, Lu W | Proceedings of the National Ac | 2019 | 0 |
| NLGN1 and NLGN2 in the prefrontal cortex: their role in memory consolidation and [PMID:29278843] | Katzman A, Alberini CM | Current opinion in neurobiolog | 2018 | 0 |
| Declining levels of functionally specialized synaptic proteins in plasma neurona [PMID:29025866] | Goetzl EJ, Abner EL, Jicha GA, Kapogiann | FASEB journal : official publi | 2018 | 0 |
| Structural Insights into Modulation of Neurexin-Neuroligin Trans-synaptic Adhesi [PMID:28641111] | ["Kim J", "Kim D", "Won S", "Han K", "Pa | Neuron | 2017 | 0 |
| Role of Neurexin-1β and Neuroligin-1 in Cognitive Dysfunction After Subarachnoid [PMID:26219651] | ["Shen H", "Chen Z", "Wang Y", "Gao A", | Stroke | 2015 | 0 |
| Evidence for Association of Cell Adhesion Molecules Pathway and NLGN1 Polymorphi [PMID:26674772] | Zhang Z, Yu H, Jiang S, Liao J, Lu T, Wa | PloS one | 2015 | 0 |
| Neurexins. [PMID:24083347] | ["Reissner C", "Runkel F", "Missler M"] | Genome biology | 2013 | 0 |
| Genetic study of neurexin and neuroligin genes in Alzheimer's disease. [PMID:23403532] | Martinez-Mir A, González-Pérez A, Gayán | Journal of Alzheimer's disease | 2013 | 0 |
| Overexpression of the cell adhesion protein neuroligin-1 induces learning defici [PMID:19437420] | ["Dahlhaus R", "Hines R", "Eadie B", "Ka | Hippocampus | 2010 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.90 · 2026-04-12
closed · Rounds: 3 · Score: 0.95 · 2026-04-04
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
Hypotheses and analyses mentioning NLGN1 in their description or question text
No additional research found